Corsetti M,Caenepeel P,Fischler B,et al.Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia[J].Am J Gastroenterol,2004,99(6):1152-1159.
Reshetnikov OV,Kurilovich SA,Denisova DV,et al.Prevalence and risk factors of the development of irritable bowel syndrome in adolescents:a population study[J].Ter Arkh,2001,73(2):24-29.
[4]
Kawamura A,Adachi K,Takashima T,et al Prevalence of irritable bowel syndrome and its relationship with Helicobacter pylor infection in a Japanese population[J].Am J Gastroenterol,2001,96(6):1946.
Andresen V,Camilleri M.Irritable bowel syndrome:recent and novel therapeutic approaches[J].Drugs,2006,66(8):1073 -1088.
[7]
Locke GR III,Talley NJ,Nelson DK,et al.Helicobacterpylori and dyspepsia:A population-based study of the organism and host[J].Am J Gastroenterol,2000,95(8):1906-1913.
[8]
Drossman DA.The functional gastrointestinal disorders and the RomeIII process[J].Gastroenterology,2006,130(5):1377- 1390.
[9]
Fuccio L,Zagari RM,Eusebi LH,et al.Meta-analysis:can Helicobacter pylori eradication treatment reduce the risk for gastric cancer[J].Ann Intern Med,2009,151:121.
[10]
Drossman DA. The functional gastrointestinal disorders and the Rome III process [J].Gastroenterology,2006,130:1377-1390.
[11]
Gerards C,Leodolter A,Glasbrenner B,et al.H.pylori infection and visceral hypersensitivity in patients with irritable bowel syndrome[J].Dig Dis,2001,19(2):170-173.
[12]
Reshetnikov OV,Kurilovich SA,Denisova DV,et al. Prevalence and risk factors of the development of irritable bowel syndrome in adolescents:a population study[J].Ter Arkh,2001,73(2):24-29.
[13]
Ford AC,Forman D,Bailey AG,et al.Initial poor quality of life and new onset of dyspepsia:results from a longitudinal 10-year follow-up study[J].Gut,2007,56(3):321-327.
[14]
Ford AC,Forman D,Bailey AG,et al.Irritable bowel syndrome:a 10-year natural history of symptoms and factors that influence consultation behavior[J].Am J Gastroenterol,2008,103(5):1229-1239.
